Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

MACSF

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 23
Average round size
info
The average size of a deal this fund participated in
$46M
Portfolio companies 19
Rounds per year 0.26
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Key employees 1

Areas of investment

  • Health Care
  • Artificial Intelligence
  • Medical
  • Software
  • Medical Device
Summary

MACSF is the famous Corporate Investor, which was founded in 1935. The venture was found in Europe in France. The main department of described Corporate Investor is located in the La Du00e9fense.

Among the various public portfolio startups of the fund, we may underline Bitfury Group For fund there is no match between the country of its foundation and the country of its the most frequent investments - The Netherlands. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Mining Technology, Mining.

The standard case for the fund is to invest in rounds with more than 10 partakers. Despite the MACSF, startups are often financed by iTech Capital, SDVentures, Georgian Co-Investment Fund. The meaningful sponsors for the fund in investment in the same round are iTech Capital, Macquarie Capital, LIAN Group.

The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2018. Deals in the range of 50 - 100 millions dollars are the general things for fund. When the investment is from MACSF the average startup value is 500 millions - 1 billion dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of MACSF:
Typical Co-investors
MACSF is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after MACSF:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BCH Angel Fund -
Beijing Zhonghai Jinyue Investment Management -
BrahmaX Ventures Calabasas, California, United States
Cato BioVentures Durham, North Carolina, United States
Chapman Office England, London, United Kingdom
eXeed Technology HaMerkaz, Israel, Savyon
Fujitsu Japan, Tokyo
Gerber Finance New York, New York, United States
J-Tech Capital Canada, Ontario, Toronto
JT Asset Management Beijing, Beijing, China
Leichen Touzi China, Guangdong, Guangzhou
Lian Fund -
Micasa Investments -
Parafi Capital Connecticut, Greenwich, United States
Taiyo Kogyo Japan, Setagaya
The Goodyear Tire & Rubber Akron, Ohio, United States
University of Minnesota Discovery Capital Investment -
VTC Seed Fund Roanoke, United States, Virginia

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Rhythm Diagnostic Systems (France)

Health Care
Medical
Medical Device
$1M01 Dec 2023 Strasbourg, Alsace, France

DocCity

Clinical Trials
Health Care
Life Science
$35M27 Nov 2023 Suresnes, Ile-de-France, France

Gleamer

Artificial Intelligence
Software
$31M28 Jun 2023 Paris, Ile-de-France, France

Intelligence Anesthesia

Health Care
Medical Device
$2M05 May 2022 Paris, Ile-de-France, France

Invivox

Health Care
Medical
Professional Services
$8M23 Mar 2022 Rennes, Brittany, France

PIXmania.com

E-Commerce
Photography
$12M14 Mar 2022 España, Guayas, Ecuador

Synapse Medicine

Health Care
Medical
Pharmaceutical
$29M01 Mar 2022 Bordeaux, New Aquitaine, France

Resilience Care

Health Care
Software
$47M25 Jan 2022 Paris, Ile-de-France, France

Wandercraft

Health Care
Medical Device
Robotics
$47M20 Jan 2022 Paris, Ile-de-France, France

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent MACSF?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 23
Average round size 46M
Rounds per year 0.26
Peak activity year 2022
Lead investments 2
Follow on index 0.17
Group Appearance index 0.96

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Rhythm Diagnostic Systems (France)

Health Care
Medical
Medical Device
$1M01 Dec 2023 Strasbourg, Alsace, France

DocCity

Clinical Trials
Health Care
Life Science
$35M27 Nov 2023 Suresnes, Ile-de-France, France

Gleamer

Artificial Intelligence
Software
$31M28 Jun 2023 Paris, Ile-de-France, France

Intelligence Anesthesia

Health Care
Medical Device
$2M05 May 2022 Paris, Ile-de-France, France

Invivox

Health Care
Medical
Professional Services
$8M23 Mar 2022 Rennes, Brittany, France

PIXmania.com

E-Commerce
Photography
$12M14 Mar 2022 España, Guayas, Ecuador

Synapse Medicine

Health Care
Medical
Pharmaceutical
$29M01 Mar 2022 Bordeaux, New Aquitaine, France

Resilience Care

Health Care
Software
$47M25 Jan 2022 Paris, Ile-de-France, France

Wandercraft

Health Care
Medical Device
Robotics
$47M20 Jan 2022 Paris, Ile-de-France, France
Crunchbase icon

Content report

The following text will be sent to our editors: